The proposal will employ molecular cloning methods to characterize prostaglandin receptor subtypes in human erythroleukemia (HEL) cells and vascular smooth muscle cells and correlate the subtypes with patterns of cyclic AMP metabolism in both cell types. Prostaglandins are potent stimulators of cyclic AMP formation in platelets and vascular smooth muscle cells, leading to inhibition of platelet aggregation and relaxation of vascular smooth muscle so that therapeutic use of prostaglandins as antiplatelet agents may be offset by unwanted vasodilation. Platelets and smooth muscle cells may possess different prostaglandin stimulatory receptors that may be targeted selectively by different drugs. Platelet adenylate cyclase appears to be controlled by both stimulatory and Inhibitory prostaglandin receptors that act together to maintain platelet homeostasis while allowing the cells to respond rapidly to appropriate activators. Similar two-receptor control of cAMP formation occurs in HEL cells, a megaryocytic cell line with many properties of platelets. Prostaglandin receptors coupled to inhibition (EP3 subtype) and activation (EP2 subtype) of adenylate cyclase have been successfully cloned and expressed in this laboratory from HEL cells. Low stringency hybridization will be used to clone the stimulatory IP prostaglandin receptor. Cloned receptors will be used to probe receptor expression in HEL cells and in reconstitution studies to determine the validity of the two receptor model of prostaglandin regulation: stimulatory and inhibitory receptors will be transfected into CHO cells alone and together to examine corresponding patterns of cAMP formation. The activity of splice variants of the EP3 receptor subtype will be examined. Prostaglandin subtypes on vascular smooth muscle cells will be compared with HEL cell receptors by cloning techniques including Northern blot analysis, high fidelity PCR screening of vascular smooth muscle total RNA, and if necessary by cloning the corresponding vascular smooth muscle receptors. Further studies will correlate radioligand prostaglandin binding with receptor subtypes expressed on the cells and with patterns of cyclic AMP metabolism that can be analyzed by computer modeling.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Temple University
Schools of Medicine
United States
Zip Code
Sakolsky, D J; Ashby, B (2001) Patterns of cyclic AMP formation by coexpressed D1 and D2L dopamine receptors in HEK 293 cells. Receptors Channels 7:479-89
Bastepe, M; Ashby, B (1999) Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor. Br J Pharmacol 126:365-71
Daniel, J L; Dangelmaier, C; Jin, J et al. (1998) Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273:2024-9
Paul, B Z; Ashby, B; Sheth, S B (1998) Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. Br J Haematol 102:1204-11
Ashby, B (1998) Co-expression of prostaglandin receptors with opposite effects: a model for homeostatic control of autocrine and paracrine signaling. Biochem Pharmacol 55:239-46
Ortiz-Vega, S; Ashby, B (1997) Human prostacyclin receptor: cloning and co-expression with EP3 prostaglandin receptor. Adv Exp Med Biol 433:235-8
Jin, J; Mao, G F; Ashby, B (1997) Constitutive activity of human prostaglandin E receptor EP3 isoforms. Br J Pharmacol 121:317-23
Bastepe, M; Ashby, B (1997) The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization. Mol Pharmacol 51:343-9
Mao, G F; Jin, J G; Bastepe, M et al. (1996) Prostaglandin E2 both stimulates and inhibits adenyl cyclase on platelets: comparison of effects on cloned EP4 and EP3 prostaglandin receptor subtypes. Prostaglandins 52:175-85
Kunapuli, S P; Fen Mao, G; Bastepe, M et al. (1994) Cloning and expression of a prostaglandin E receptor EP3 subtype from human erythroleukaemia cells. Biochem J 298 ( Pt 2):263-7